<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=CD20</id>
	<title>CD20 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=CD20"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=CD20&amp;action=history"/>
	<updated>2026-10-18T09:29:31Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=CD20&amp;diff=16422&amp;oldid=prev</id>
		<title>Paul.xu at 21:36, 28 August 2017</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=CD20&amp;diff=16422&amp;oldid=prev"/>
		<updated>2017-08-28T21:36:54Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:CD20-molecule-and-the-binding-sites-of-rituximab-ofatumumabReprinted-with.png|RTENOTITLE]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
B-lymphocyte antigen CD20 MS4A1&lt;br /&gt;
&lt;br /&gt;
http://www.uniprot.org/uniprot/P11836&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
NM_021950  &lt;br /&gt;
MTTPRNSVNG TFPAEPMKGP IAMQSGPKPL FRRMSSLVGP TQSFFMRESK &lt;br /&gt;
        60         70         80         90        100&lt;br /&gt;
TLGAVQIMNG LFHIALGGLL MIPAGIYAPI CVTVWYPLWG GIMYIISGSL &lt;br /&gt;
       110        120        130        140        150&lt;br /&gt;
LAATEKNSRK CLVKGKMIMN SLSLFAAISG MILSIMDILN IKISHFLKME &lt;br /&gt;
       160        170        180        190        200&lt;br /&gt;
SLNFIRAHTP YINIYNCEPA NPSEKNSPST QYCYSIQSLF LGILSVMLIF &lt;br /&gt;
       210        220        230        240        250&lt;br /&gt;
AFFQELVIAG IVENEWKRTC SRPKSNIVLL SAEEKKEQTI EIKEEVVGLT &lt;br /&gt;
       260        270        280        290 &lt;br /&gt;
ETSSQPKNEE DIEIIPIQEE EEEETETNFP EPPQDQESSP IENDSSP&lt;br /&gt;
&lt;br /&gt;
Topological domaini	1 – 56	CytoplasmicS 56&lt;br /&gt;
Transmembranei	57 – 78	Helical		22&lt;br /&gt;
Topological domaini	79 – 84	Extracellular 		6&lt;br /&gt;
Transmembranei	85 – 105	HelicalS 	21&lt;br /&gt;
Topological domaini	106 – 120	Cytoplasmic 		15&lt;br /&gt;
Transmembranei	121 – 141	Helical 		21&lt;br /&gt;
Topological domaini	142 – 188	Extracellular 		47&lt;br /&gt;
Transmembranei	189 – 209	Helical 	21&lt;br /&gt;
Topological domaini	210 – 297	Cytoplasmic &lt;br /&gt;
&lt;br /&gt;
CD20 antigen; CD20 receptor; B-lymphocyte&lt;br /&gt;
cell-surface antigen B1; membrane-spanning 4-domains,&lt;br /&gt;
subfamily A, member 1; leukocyte surface antigen Leu-16&lt;br /&gt;
&lt;br /&gt;
ATGACAACACCCAGAAATTCAGTAAATGGGACTTTCCCGGCAGAGCCAATGAAAGGCCCTATTGCTATGCAATCTGGTCCAAAACCACTCTTCAGGAGGATGTCTTCACTGGTGGGCCCCACGCAAAGCTTCTTCATGAGGGAATCTAAGACTTTGGGGGCTGTCCAGATTATGAATGGGCTCTTCCACATTGCCCTGGGGGGTCTTCTGATGATCCCAGCAGGGATCTATGCACCCATCTGTGTGACTGTGTGGTACCCTCTCTGGGGAGGCATTATGTATATTATTTCCGGATCACTCCTGGCAGCAACGGAGAAAAACTCCAGGAAGTGTTTGGTCAAAGGAAAAATGATAATGAATTCATTGAGCCTCTTTGCTGCCATTTCTGGAATGATTCTTTCAATCATGGACATACTTAATATTAAAATTTCCCATTTTTTAAAAATGGAGAGTCTGAATTTTATTAGAGCTCACACACCATATATTAACATATACAACTGTGAACCAGCTAATCCCTCTGAGAAAAACTCCCCATCTACCCAATACTGTTACAGCATACAATCTCTGTTCTTGGGCATTTTGTCAGTGATGCTGATCTTTGCCTTCTTCCAGGAACTTGTAATAGCTGGCATCGTTGAGAATGAATGGAAAAGAACGTGCTCCAGACCCAAATCTAACATAGTTCTCCTGTCAGCAGAAGAAAAAAAAGAACAGACTATTGAAATAAAAGAAGAAGTGGTTGGGCTAACTGAAACATCTTCCCAACCAAAGAATGAAGAAGACATTGAAATTATTCCAATCCAAGAAGAGGAAGAAGAAGAAACAGAGACGAACTTTCCAGAACCTCCCCAAGATCAGGAATCCTCACCAATAGAAAATGACAGCTCTCCTTA&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:CD20 antibody.png|RTENOTITLE]]&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>